Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0C9MJ
|
|||
| Drug Name |
Anti-MUC1 CAR-T cells
|
|||
| Drug Type |
CAR T Cell Therapy
|
|||
| Indication | Colorectal cancer [ICD-11: 2B91.Z] | Phase 1/2 | [1] | |
| Gastric adenocarcinoma [ICD-11: 2B72; ICD-9: 151] | Phase 1/2 | [1] | ||
| Malignant glioma [ICD-11: 2A00.0; ICD-9: 191] | Phase 1/2 | [1] | ||
| Company |
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Mucin-1 (MUC1) | Target Info | CAR-T-Cell-Therapy | [1] |
| WikiPathways | Hematopoietic Stem Cell Differentiation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02617134) CAR-T Cell Immunotherapy in MUC1 Positive Solid Tumor | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.